PMID- 25031858 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20140717 LR - 20240321 IS - 2074-1804 (Print) IS - 2074-1812 (Electronic) IS - 2074-1804 (Linking) VI - 16 IP - 5 DP - 2014 May TI - Hydro-methanolic extract of cornus MAS L. And blood glucose, lipid profile and hematological parameters of male rats. PG - e17784 LID - 10.5812/ircmj.17784 [doi] LID - e17784 AB - BACKGROUND: Cornus mas L, an olive-shaped red-colored single-seeded fruit, is used in traditional medicine in different parts of Europe and Asia. OBJECTIVES: In the present study, 40 male Wistar rats were randomly divided into five groups, and the effects of 21 days of intraperitoneally (IP) administration of 50, 200 and 400 mg/kg body weight of C. mas hydro-methanolic extract on the rats hematological and biochemical parameters were investigated. The experimental study was carried out in Tabriz, Iran. MATERIALS AND METHODS: The hematology and biochemical tests were performed by the Technicon H1 Hematology Analyzer and enzymatic methods, respectively. RESULTS: The results indicated that all doses of the extract caused significant (P < 0.05) decreases in the hemoglobin distribution width (HDW) (2.3 +/- 0.2 vs. 2.5 +/- 0.2, P = 0.049) and platelet distribution width (PDW) (56.5 +/- 1.8 vs. 63.9 +/- 3.6, P = 0.001) of the treated groups vs. control group, whereas only high doses caused significant elevation in the mean corpuscular hemoglobin concentration (MCHC) (30.3 +/- 0.8 vs. 28.6 +/- 0.6, P = 0.047), mean platelet volume (MPV) (5.0 +/- 0.6 vs. 4.1 +/- 0.3, P = 0.002), total platelet mass (PCT) (0.33 +/- 0.07 vs. 0.26 +/- 0.01, P = 0.050), and significant decrease in the red cell distribution width (RDW) (13.8 +/- 0.4 vs. 14.7 +/- 1.3, P = 0.048) of the treated groups vs. control group. CONCLUSIONS: Decreasing effect of the extract on platelet activity might classify it as an alternative for antiplatelet therapy in cardiovascular diseases (CVD). The results of this study suggested that further investigations with higher doses of C. mas fruit extract are necessary to obtain significant protective and nonprotective changes in hematological and biochemical parameters. FAU - Abdollahi, Bita AU - Abdollahi B AD - Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran. FAU - Mesgari Abbasi, Mehran AU - Mesgari Abbasi M AD - Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran ; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, IR Iran. FAU - Zakeri Milani, Parvin AU - Zakeri Milani P AD - Student Research Committee, Tabriz University of Medical Sciences, Tabriz, IR Iran. FAU - Nourdadgar, Ashraf Sadat AU - Nourdadgar AS AD - Medical Education Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran. FAU - Banan Khojasteh, Seyyed Mehdi AU - Banan Khojasteh SM AD - Department of Natural Sciences, Faculty of Natural Sciences, University of Tabriz, Tabriz, IR Iran. FAU - Nejati, Vahid AU - Nejati V AD - Faculty of Science, Urmia University, Urmia, IR Iran. LA - eng PT - Journal Article DEP - 20140505 PL - Estonia TA - Iran Red Crescent Med J JT - Iranian Red Crescent medical journal JID - 101319850 PMC - PMC4082518 OTO - NOTNLM OT - Biological Markers OT - Blood Glucose OT - Cornus OT - Hematologic Tests EDAT- 2014/07/18 06:00 MHDA- 2014/07/18 06:01 PMCR- 2014/05/01 CRDT- 2014/07/18 06:00 PHST- 2014/01/23 00:00 [received] PHST- 2014/03/19 00:00 [revised] PHST- 2014/04/01 00:00 [accepted] PHST- 2014/07/18 06:00 [entrez] PHST- 2014/07/18 06:00 [pubmed] PHST- 2014/07/18 06:01 [medline] PHST- 2014/05/01 00:00 [pmc-release] AID - 10.5812/ircmj.17784 [doi] PST - ppublish SO - Iran Red Crescent Med J. 2014 May;16(5):e17784. doi: 10.5812/ircmj.17784. Epub 2014 May 5.